Skip to main content

What Illumina's FY2025 10-K says: 7 signals

Illumina filed its latest 10-K with the SEC on Feb 11, 2026. It discusses restructuring, chief commercial officer change and general counsel change.

Public (ILMN)Biotechnology Research10,000+ employeesillumina.comLinkedIn

Filed
Feb 11, 2026
Period
FY2025
Fiscal year end
12/28
Filings
1

10-K · latest 7

What Illumina's 10-K filings say

  1. 10-K · FY2025

    Filed · Fiscal year ends 12/28 · 7 signals

    SEC EDGAR

Signal API · MCP

Track Illumina with the Signal API

One POST /v1/companies/enrich call with illumina.com returns Illumina 10-K signals (sec-10k), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"illumina.com","signal_types":["sec-10k"],"limit":20}'

Same industry

Questions about Illumina 10-K

When did Illumina file its latest 10-K?
Illumina filed its latest 10-K (FY2025) on Feb 11, 2026.
What does Illumina's latest 10-K say about chief commercial officer change?
From the filing dated Feb 11, 2026: Chief Commercial Officer Everett Cunningham departed Illumina on January 16, 2026.
Where can I find Illumina's annual report?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/ilmn-20251228.htm. This page summarizes what the filing says and links to it.

Source. Annual reports (Form 10-K) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →